Skip to Main Content

Evaluation of Resynchronization Therapy for Heart Failure (EARTH)

This study has been completed.

Sponsor:

Collaborators:

St. Jude Medical

Canadian Institutes of Health Research (CIHR)

Information provided by (Responsible Party):

Bernard Thibault, Montreal Heart Institute

ClinicalTrials.gov Identifier:

NCT00901212

First received: May 12, 2009

Last updated: May 6, 2012

Last verified: May 2012

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	February 2010
Primary Completion Date:	February 2010 (Final data collection date for primary outcome measure)

No publications provided by Montreal Heart Institute

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Thibault B, Ducharme A, Harel F, White M, O'Meara E, Guertin MC, Lavoie J, Frasure-Smith N, Dubuc M, Guerra P, Macle L, Rivard L, Roy D, Talajic M, Khairy P; Evaluation of Resynchronization Therapy for Heart Failure (GREATER-EARTH) Investigators. Left ventricular versus simultaneous biventricular pacing in patients with heart failure and a QRS complex ?120 milliseconds. Circulation. 2011 Dec 20;124(25):2874-81. Epub 2011 Nov 21.

Thibault B, Harel F, Ducharme A, White M, Frasure-Smith N, Roy D, Philippon F, Dorian P, Talajic M, Dubuc M, Gagné P, Guerra PG, Macle L, Rivard L, Khairy P. Evaluation of resynchronization therapy for heart failure in patients with a QRS duration greater than 120 ms (GREATER-EARTH) trial: rationale, design, and baseline characteristics. Can J Cardiol. 2011 Nov;27(6):779-86. Epub 2011 Jul 24.